Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland
Saneca Pharmaceuticals, a.s. (Saneca) has acquired Suir Pharma Ireland from mutares AG, an industrial holding company. Financial details have not been disclosed.
Saneca is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns a portfolio of cosmetic and generic products.
Suir Pharma Ireland is an independent contract manufacturing company working with many established pharmaceutical companies worldwide. Formerly a Stada AG manufacturing site, Suir Pharma Ireland is well known as an established manufacturer of generic medicines for more than 40 years with the highest quality standards. The company supplies various markets in Europe and the USA.
mutares AG is an industrial holding company that focuses on the acquisition of companies currently finding themselves in a special situation, such as owner or management succession, strategic repositioning and re-funding.
Oaklins' team in Slovakia advised the buyer in this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more